Downloads
Article: CMO PAT Implementation: Time For Strategic Decisions
By Rebecca Vangenechten
Process analytical technology (PAT) is a vital step towards a future where continuous manufacturing and real time product release can become real in the pharmaceutical sector. After a slow start, PAT is high on the agenda for Big Pharma. But it is not so common among contract manufacturers (CMOs). What is holding them back and what are the issues they need to consider? Rebecca Vangenechten argues that, while the pace of change will vary from company to company, all CMOs need to have a PAT strategy in place.
Used with permission from Life Science Leader magazine.
The content you requested is only available to registered users of Bioresearch Online. By registering now, you'll get access to this piece of content and thousands of additional articles and product reviews across our entire network of sites.
